An experimental study of the composition for medicament corneal crosslinking as a promising means for keratoconus treatment

The deterioration of the corneal framing function in keratoconus is largely due to the dystrophic process and the decrease of collagen structures crosslinking level. The purpose of the study is to perform a preclinical placebo controlled study of the safeness and effectiveness of Cornetex compound i...

Full description

Saved in:
Bibliographic Details
Main Authors: E. N. Iomdina, A. R. Korigodsky, I. P. Khoroshilova-Maslova, L. D. Andreeva, N. Yu. Ignatieva
Format: Article
Language:Russian
Published: Real Time Ltd 2018-10-01
Series:Российский офтальмологический журнал
Subjects:
Online Access:https://roj.igb.ru/jour/article/view/123
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849696563748667392
author E. N. Iomdina
A. R. Korigodsky
I. P. Khoroshilova-Maslova
L. D. Andreeva
N. Yu. Ignatieva
author_facet E. N. Iomdina
A. R. Korigodsky
I. P. Khoroshilova-Maslova
L. D. Andreeva
N. Yu. Ignatieva
author_sort E. N. Iomdina
collection DOAJ
description The deterioration of the corneal framing function in keratoconus is largely due to the dystrophic process and the decrease of collagen structures crosslinking level. The purpose of the study is to perform a preclinical placebo controlled study of the safeness and effectiveness of Cornetex compound instillations for medicament corneal crosslinking. Material and methods. The study included 37 Chinchilla rabbits (74 eyes). 33 rabbits received Cornetex solution instillations into one eye twice a day for 1 month (17 rabbits, 1st series) and for 3 months (16 rabbits, 2nd series). The active constituents of Cornetex include a complex of the basic amino acid salts in the form of succinates (residues of succinate acid) participating in collagen crosslinking formation. The placebo solution containing nonactive Cornetex constituents (Hydroxyethyl cellulose, benzalkonium chloride and water for injections) was instilled into fellow eyes. 4 fully intact rabbits (8 eyes) served as an independent control group. In vivo methods included biomicroscopy and examination with a Scheimpflug camera Galilei G2. 1 and 3 months after the instillation course, the eyes were enucleated and subjected to a morphological study, biomechanical testing of corneal samples (on the testing machine Autograph AGS-H). Corneal collagen crosslinking level was determined by differential scanning calorimetry using a Phoenix DSC 204 calorimeter. Results. Biomicroscopic and morphological studies revealed no pathological changes of ocular media and tissues. One month after the instillation course, the collagen crosslinking level of the cornea showed a 18 to 20 % increase, while its elasticity modulus showed a 1.8-fold increase with respect to the fellow eye, which is an evidence of the safety and high corneal reinforcement effect of the instillations. Conclusions. The outcome of the experimental study of Cornetex implies that it can be recommended for further clinical studies as a promising means for keratoconus treatment. For citations: Iomdina E.N., Korigodsky A.R., Khoroshilova-Maslova I.P., Andreeva L.D., Ignatieva N.Yu. An experimental study of the composition for medicament corneal crosslinking as a promising means for keratoconus treatment. Russian ophthalmological journal. 2017; 10 (4): 54-61. doi: 10.21516/2072-0076-2017-10-4-54-61 (In Russian).
format Article
id doaj-art-3b8779b12f7d4f94bfc3bd14fff2a8e2
institution DOAJ
issn 2072-0076
2587-5760
language Russian
publishDate 2018-10-01
publisher Real Time Ltd
record_format Article
series Российский офтальмологический журнал
spelling doaj-art-3b8779b12f7d4f94bfc3bd14fff2a8e22025-08-20T03:19:25ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602018-10-01104546110.21516/2072-0076-2017-10-4-54-61123An experimental study of the composition for medicament corneal crosslinking as a promising means for keratoconus treatmentE. N. Iomdina0A. R. Korigodsky1I. P. Khoroshilova-Maslova2L. D. Andreeva3N. Yu. Ignatieva4Moscow Helmholtz Research Institute of Eye DiseasesHighBeTech LtdMoscow Helmholtz Research Institute of Eye DiseasesMoscow Helmholtz Research Institute of Eye DiseasesLomonosov Moscow State UniversityThe deterioration of the corneal framing function in keratoconus is largely due to the dystrophic process and the decrease of collagen structures crosslinking level. The purpose of the study is to perform a preclinical placebo controlled study of the safeness and effectiveness of Cornetex compound instillations for medicament corneal crosslinking. Material and methods. The study included 37 Chinchilla rabbits (74 eyes). 33 rabbits received Cornetex solution instillations into one eye twice a day for 1 month (17 rabbits, 1st series) and for 3 months (16 rabbits, 2nd series). The active constituents of Cornetex include a complex of the basic amino acid salts in the form of succinates (residues of succinate acid) participating in collagen crosslinking formation. The placebo solution containing nonactive Cornetex constituents (Hydroxyethyl cellulose, benzalkonium chloride and water for injections) was instilled into fellow eyes. 4 fully intact rabbits (8 eyes) served as an independent control group. In vivo methods included biomicroscopy and examination with a Scheimpflug camera Galilei G2. 1 and 3 months after the instillation course, the eyes were enucleated and subjected to a morphological study, biomechanical testing of corneal samples (on the testing machine Autograph AGS-H). Corneal collagen crosslinking level was determined by differential scanning calorimetry using a Phoenix DSC 204 calorimeter. Results. Biomicroscopic and morphological studies revealed no pathological changes of ocular media and tissues. One month after the instillation course, the collagen crosslinking level of the cornea showed a 18 to 20 % increase, while its elasticity modulus showed a 1.8-fold increase with respect to the fellow eye, which is an evidence of the safety and high corneal reinforcement effect of the instillations. Conclusions. The outcome of the experimental study of Cornetex implies that it can be recommended for further clinical studies as a promising means for keratoconus treatment. For citations: Iomdina E.N., Korigodsky A.R., Khoroshilova-Maslova I.P., Andreeva L.D., Ignatieva N.Yu. An experimental study of the composition for medicament corneal crosslinking as a promising means for keratoconus treatment. Russian ophthalmological journal. 2017; 10 (4): 54-61. doi: 10.21516/2072-0076-2017-10-4-54-61 (In Russian).https://roj.igb.ru/jour/article/view/123роговицапоперечные сшивкиосновные аминокислотысукцинатымодуль упругостикератоконусcrosslinkingbasic amino acidssuccinateselasticity moduluskeratoconus
spellingShingle E. N. Iomdina
A. R. Korigodsky
I. P. Khoroshilova-Maslova
L. D. Andreeva
N. Yu. Ignatieva
An experimental study of the composition for medicament corneal crosslinking as a promising means for keratoconus treatment
Российский офтальмологический журнал
роговица
поперечные сшивки
основные аминокислоты
сукцинаты
модуль упругости
кератоконус
crosslinking
basic amino acids
succinates
elasticity modulus
keratoconus
title An experimental study of the composition for medicament corneal crosslinking as a promising means for keratoconus treatment
title_full An experimental study of the composition for medicament corneal crosslinking as a promising means for keratoconus treatment
title_fullStr An experimental study of the composition for medicament corneal crosslinking as a promising means for keratoconus treatment
title_full_unstemmed An experimental study of the composition for medicament corneal crosslinking as a promising means for keratoconus treatment
title_short An experimental study of the composition for medicament corneal crosslinking as a promising means for keratoconus treatment
title_sort experimental study of the composition for medicament corneal crosslinking as a promising means for keratoconus treatment
topic роговица
поперечные сшивки
основные аминокислоты
сукцинаты
модуль упругости
кератоконус
crosslinking
basic amino acids
succinates
elasticity modulus
keratoconus
url https://roj.igb.ru/jour/article/view/123
work_keys_str_mv AT eniomdina anexperimentalstudyofthecompositionformedicamentcornealcrosslinkingasapromisingmeansforkeratoconustreatment
AT arkorigodsky anexperimentalstudyofthecompositionformedicamentcornealcrosslinkingasapromisingmeansforkeratoconustreatment
AT ipkhoroshilovamaslova anexperimentalstudyofthecompositionformedicamentcornealcrosslinkingasapromisingmeansforkeratoconustreatment
AT ldandreeva anexperimentalstudyofthecompositionformedicamentcornealcrosslinkingasapromisingmeansforkeratoconustreatment
AT nyuignatieva anexperimentalstudyofthecompositionformedicamentcornealcrosslinkingasapromisingmeansforkeratoconustreatment
AT eniomdina experimentalstudyofthecompositionformedicamentcornealcrosslinkingasapromisingmeansforkeratoconustreatment
AT arkorigodsky experimentalstudyofthecompositionformedicamentcornealcrosslinkingasapromisingmeansforkeratoconustreatment
AT ipkhoroshilovamaslova experimentalstudyofthecompositionformedicamentcornealcrosslinkingasapromisingmeansforkeratoconustreatment
AT ldandreeva experimentalstudyofthecompositionformedicamentcornealcrosslinkingasapromisingmeansforkeratoconustreatment
AT nyuignatieva experimentalstudyofthecompositionformedicamentcornealcrosslinkingasapromisingmeansforkeratoconustreatment